文献速递中医内科针灸推拿中药与中成药合理使用

中药调控小胶质细胞极化抗阿尔茨海默病进展

Progress of Chinese Medicine in Regulating Microglial Polarization against Alzheimer's Disease.
PubMed 文献 · Am J Chin Med · 2024-12-24

本文综述阿尔茨海默病(AD)中小胶质细胞(MG)的起源、极化动态及其与AD病理的机制关联,并汇总近三年中药单体、复方与针刺通过调控MG极化治疗AD的策略,为临床与基础研究提供理论框架。

要点

  • MG具神经保护与促炎双重作用,其极化动态是AD进展的关键环节
  • 中药单体、复方及针刺可通过调控MG极化干预AD病理
  • 该综述为AD的中药临床与临床前研究提供理论框架

核心结论

  • 中药单体、复方与针刺可通过调控小胶质细胞极化干预AD,为后续临床与临床前研究提供理论框架。

研究设计与样本

  • 综述:检索并汇总近三年中药调控小胶质细胞极化治疗阿尔茨海默病的研究进展。

主要发现

  • 小胶质细胞表达清道夫受体,可促进β-淀粉样蛋白(Aβ)与细胞碎片的清除。
  • 小胶质细胞异常激活可分泌促炎细胞因子,推动神经炎症并损害神经元完整性。
  • MG极化与Aβ斑块沉积、tau过度磷酸化、突触可塑性受损、神经炎症及脑肠轴失调等AD核心病理相关。
  • 中药干预策略涵盖单体、复方与针刺三类,均涉及对MG极化的调控。

关键数值与推荐

  • AD占全部痴呆病例的60-70%,目前缺乏治愈性疗法。

临床怎么用

  • 解读AD中药与针刺研究时,可将MG极化(促炎/神经保护表型)作为机制评价的核心环节。
  • 评估中药单体或复方抗AD证据时,可对照Aβ沉积、tau磷酸化、突触可塑性、神经炎症与脑肠轴等病理终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alzheimer's disease (AD), the predominant form of dementia, is a neurodegenerative disorder of the central nervous system (CNS) characterized by a subtle onset and a spectrum of cognitive and functional declines. The clinical manifestation of AD encompasses memory deficits, cognitive deterioration, and behavioral disturbances, culminating in a severe impairment of daily living skills. Despite its high prevalence, accounting for 60-70% of all dementia cases, there remains an absence of curative therapeutics. Microglia (MG), the resident immune cells of the CNS, exhibit a bifurcated role in AD pathogenesis. Functioning in a neuroprotective capacity, MGs express scavenger receptors, facilitating the clearance of [Formula: see text]-amyloid protein (A[Formula: see text]) and cellular debris. Conversely, aberrant activation of MGs can lead to the secretion of pro-inflammatory cytokines, thereby propagating neuroinflammatory responses that are detrimental to neuronal integrity. The dynamics of MG activation and the ensuing neuroinflammation are pivotal in the evolution of AD. Chinese medicine (CM), a treasure trove of traditional Chinese cultural practices, has demonstrated significant potential in the therapeutic management of AD. Over the past triennium, CM has garnered considerable research attention for its multifaceted approaches to AD, including the regulation of MG polarization. This review synthesizes current knowledge on the origins, polarization dynamics, and mechanistic interplay of MG with AD pathology. It further explores the nexus between MG polarization and cardinal pathological hallmarks of AD, such as A[Formula: see text] plaque deposition, hyperphosphorylation of tau, synaptic plasticity impairments, neuroinflammation, and brain-gut-axis dysregulation. The review also encapsulates the therapeutic strategies of CM, which encompass monomers, formulae, and acupuncture. These strategies modulate MG polarization in the context of AD treatment, thereby providing a robust theoretical framework in which to conduct future investigative endeavors in both the clinical and preclinical realms.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Yang F, Gao W, Wang J, et al. Progress of Chinese Medicine in Regulating Microglial Polarization against Alzheimer's Disease. Am J Chin Med. 2024. PMID: 39721955. doi:10.1142/S0192415X24500873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。